Further Information:
The Health Products Regulatory Authority has been notified of a shortage of the following products:
- Enerzair Breezhaler 114mcg /46mcg/136mcg Inhalation Powder - EU/1/20/1438/003
- Inegy 10mg/20mg Tablets - PA23198/024/002
- Lopid 600mg Film Coated Tablets - PA0822/014/002
- Octreotide 500mcg/1ml Solution for Injection - PA0822/218/004
- Rivotril 0.5mg Tablets - PA2239/020/001
The following shortages have been resolved and supply has resumed to the Irish market:
- Aldactone 25mg Film Coated Tablets - PA0822/110/001
- Fucibet 20mg/g + 1mg/g Cream - PA0046/040/001
- Lantus 100 Units/ml Solution for Injection in a Vial - EU/1/00/134/012
- Levobupivacaine 1.25mg/ml Solution for Infusion - PA2059/009/002
- Minims Tropicamide 0.5% w/v Eye Drops - PA23259/023/001
- Miochol-E 20mg Powder and Solvent for Instillation Solution for Intraocular use - PA1245/002/001
- OxyContin 10mg Prolonged Release Tablets - PA1688/005/002
- Provigil 200mg Tablets - PA0749/198/002
- RoActemra 20mg/ml Concentrate for Solution for Infusion - EU/1/08/492/001
- Skinoren 15% Gel - PA1025/009/001
- Tritace 10mg Tablets - PA0540/084/008
- Vidisic Preservative Free Single Dose Unit - PA23259/008/002
Please see the shortages section of the HPRA website for further information
The HPRA sends weekly updates concerning medicinal product shortages. However, the above webpage will be updated as new information is provided to the HPRA.